Watson Pharmaceuticals Inc. (WPI) is in the Pharma Industry

• Sort by
• View by Content Type

• Watson Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Yes, Ma’am. [Operator instructions] Your first question comes from the line of Tim Chang with FTN Midwest Reasearch. Tim Chang I just wanted to get an update on the generic pipeline, I think you just sort of mentioned one of the key products in that...

  Earnings calls 2008-10-29

  Tags: Asset, Call Transcript, Needle, Earnings, Watson Pharmaceuticals Inc., Asset Management, Operational Planning, Business Operations, Seeking Alpha

• Watson Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Operator Instructions Your first question comes from Rich Silver - Lehman Brothers. Rich Silver – Lehman Brothers Maybe you could elaborate a little bit on what’s happening in the OCs. You mentioned you’re seeing some movement from generic to new brands. Just to talk a...

  Earnings calls 2008-09-08

  Tags: Watson Pharmaceuticals Inc.

• Watson to Present at the Morgan Stanley Global Healthcare Unplugged Conference

  Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at 4:30 p.m. Eastern Daylight Time....

  Research articles 2008-09-03

  Tags: Morgan Stanley, Watson Pharmaceuticals Inc.

• Thursday Options Outlook: WPI, ADSK, DNA, NITE, LEN, CTRP, FRX, IDCC

  Rebecca Engmann Darst contributed to this report. Watson Pharmaceuticals WPI – Yesterday we seized upon a 14-fold increase in option trading volume in Watson Pharmaceuticals that had a whiff of deal jockeying to it. The company has previously moved on diffuse takeover chatter (most recently on July 21), and we...

  External links 2008-08-14

  Tags: US Market, Autodesk Inc., Ctrip Com International Ltd., Genentech Inc., Forest Laboratories Inc., InterDigital Communications Corp., Lennar Corp., Knight Capital Group Inc., Watson Pharmaceuticals Inc.

• Wednesday Options Outlook: KRE, STI, WPI, IYR, BGG, SWY

  Rebecca Engmann Darst co-authored this article. KBW Regional Banking ETF KRE ? Regional banks continue to be a particularly raw bruise site in the already-buffeted financial sector. Option traders continue to seek out unusual out-of-the-money put positions in the KBW Regional Banking ETF. With the index share price down...

  External links 2008-08-13

  Tags: US Market, Briggs & Stratton Corp., SunTrust Banks Inc., Safeway Inc., Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from David Buck with Buckingham Research. David Buck - Buckingham Research Thanks for taking my question. Paul, a couple of questions for you. If I could just get a sense of what you are expecting the plant closure savings to be...

  Earnings calls 2008-05-01

  Tags: Watson Pharmaceuticals Inc.

• Healthcare Stocks to Watch: HSXI, HEPH, OPXA, WPI.

  M2 PRESSWIRE-12 March 2008-Financialbusinessnews.us: Healthcare Stocks to Watch: HSXI, HEPH, OPXA, WPIC1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 Boston, MA -- HealthSonix, Inc. (OTC: HSXI); Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH); Opexa Therapeutics, Inc. (NASDAQ: OPXA); Watson Pharmaceuticals, Inc. (NYSE: WPI) ...

  Research articles 2008-03-12

  Tags: Benefits, Company, efficacy, HEALTHCARE, Nasdaq Stock Market Inc., Opexa Therapeutics Inc., patient, SOFTWARE, therapy, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals Inc. Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Greg Gilbert with Merrill Lynch. Patty Eisenhaur Good morning Greg. Greg Gilbert - Merrill Lynch Good morning. I will ask a couple upfront and then get back in line. First, can you quantify what '08 guidance would...

  Earnings calls 2008-02-20

  Tags: Watson Pharmaceuticals Inc.

• Watson to Present at the JP Morgan 26th Annual Healthcare Conference

  Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the JP Morgan 26th Annual Healthcare Conference on Monday, January 7, 2008 at 4:30 p.m. Pacific Standard Time....

  Research articles 2007-12-31

  Tags: J.P. Morgan Chase & Co., Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals Inc. Q3 2007 Earnings Call Transcript

  Question-and-Answer Session Operator [Operator Instructions]. We will for just a moment to compile the Q&A roster. Your first question comes from Greg Gilbert with Merrill Lynch. Gregory Gilbert - Merrill Lynch Thanks good morning. I have a couple of...

  Earnings calls 2007-11-06

  Tags: Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals Q2 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Elliot Wilbur with CIBC World Markets. Elliot Wilbur - CIBC World Markets And thank you. And before ask the question Allen, I just want to thank you for your many years of wisdom, insight...

  Earnings calls 2007-08-02

  Tags: Watson Pharmaceuticals Inc.

• Significant Double Digit Moves Over 70% Following News.

  VANCOUVER, BRITISH COLUMBIA, Mar 28, 2002 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was Aksys, Ltd. (NASDAQ: AKSY), a pioneer in innovative dialysis systems, announcing Wednesday that the Company received...

  Research articles 2002-03-28

  Tags: Benefits, Company, FINANCE, Government, Investment, Nasdaq Stock Market Inc., stock, Watson Pharmaceuticals Inc.

Additional Resources

• Watson Announces the NDA for a 6-Month Formulation of TRELSTAR® Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer

  CORONA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that its New Drug Application NDA for a 6-month formulation of TRELSTARR triptorelin pamoate, a luteinizing hormone releasing hormone LHRH agonist, has been accepted for filing by the U.S. Food and Drug...

  Articles 2008-11-13

• Debiopharm Announces U.S. NDA Filing of Trelstar® 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer

  LAUSANNE, Switzerland, Nov. 13 /PRNewswire/ -- Debiopharm Group Debiopharm, a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced that the New Drug Application NDA for the 6 month formulation of TrelstarR triptorelin pamoate has been accepted for filing by the United States...

  Articles 2008-11-13

• Zacks Industry Rank Analysis Highlights: Alpharma, Amgen, Discovery Laboratories, Teva Pharmaceutical Industries and Watson Pharmaceuticals

  CHICAGO -- Zacks.com releases the latest Zacks Industry Rank. Stocks featured in this week's analysis includes Alpharma (NYSE: ALO), Amgen (Nasdaq: AMGN), Discovery Laboratories (Nasdaq: DSCO), Teva Pharmaceutical Industries (Nasdaq: TEVA) and Watson Pharmaceuticals (NYSE: WPI). To see the Zacks Industry Rank and the trend in earnings estimates...

  Articles 2008-11-13

• Research and Markets: This Pharma Company Profile on Watson Pharmaceuticals Is Now Available

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/85462f/pharma_company_pro) has announced the addition of the "Pharma Company Profiles - Watson Pharmaceuticals" report to their offering. The success of pharmaceutical companies has always been driven by the successful launches of blockbusters. Now the environment confronting the industry is getting increasingly challenging,...

  Articles 2008-11-10

• Watson to Present at the 2008 Annual Credit Suisse Health Care Conference

  Watson Pharmaceuticals, Inc. (NYSE: WPI), aleading specialty pharmaceutical company, announced today that Paul Bisaro,Watson's president and chief executive officer, will provide an overviewand update of the Company's business at the 2008 Annual Credit SuisseHealth Care Conference on Wednesday, November 12, 2008 at 8:00 a.m.Mountain Standard Time. This presentation will be...

  Articles 2008-11-06

• Watson Pharmaceuticals Reports Third Quarter 2008 Results

  Total Net Revenue of $641 Million; GAAP EPS $0.62; Adjusted EPS $0.47 CORONA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2008. Third Quarter 2008 Results ...

  Articles 2008-10-29

• Fitch Affirms Watson Pharmaceuticals' IDR at 'BBB-'; Outlook Stable

  CHICAGO -- Fitch has affirmed Watson Pharmaceuticals, Inc.'s (Watson; NYSE: WPI) ratings as follows: --Issuer Default Rating IDR at 'BBB-'; --Senior unsecured debt at 'BBB-'; --Bank loan debt at 'BBB-'. The Rating Outlook is Stable. Watson's ratings reflect the company's declining debt...

  Articles 2008-10-27

• Watson wins O.K

  Watson Pharmaceuticals Inc. has received approval for Rapaflo, a treatment for enlarged prostate. Chief executive officer Paul Bisaro calls the approval a milestone for Watson's brand division...

  Articles 2008-10-27